Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20111 | 412 | 27.4 | 63% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
121 | 23330 | IRRITABLE BOWEL SYNDROME//NEUROGASTROENTEROLOGY AND MOTILITY//FUNCTIONAL DYSPEPSIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CISAPRIDE | Author keyword | 31 | 26% | 25% | 103 |
2 | KW 5092 | Author keyword | 11 | 78% | 2% | 7 |
3 | CINITAPRIDE | Author keyword | 3 | 35% | 1% | 6 |
4 | NORCISAPRIDE | Author keyword | 1 | 50% | 0% | 2 |
5 | ANTINAUSEANT | Author keyword | 1 | 50% | 0% | 1 |
6 | CARDIOVASC MED MINIST EDUC | Address | 1 | 50% | 0% | 1 |
7 | CAS 81098 60 4 | Author keyword | 1 | 50% | 0% | 1 |
8 | CHOLINE ESTERASE INHIBITOR | Author keyword | 1 | 50% | 0% | 1 |
9 | CISPARIDE | Author keyword | 1 | 50% | 0% | 1 |
10 | CLAIM DATA | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CISAPRIDE | 31 | 26% | 25% | 103 | Search CISAPRIDE | Search CISAPRIDE |
2 | KW 5092 | 11 | 78% | 2% | 7 | Search KW+5092 | Search KW+5092 |
3 | CINITAPRIDE | 3 | 35% | 1% | 6 | Search CINITAPRIDE | Search CINITAPRIDE |
4 | NORCISAPRIDE | 1 | 50% | 0% | 2 | Search NORCISAPRIDE | Search NORCISAPRIDE |
5 | ANTINAUSEANT | 1 | 50% | 0% | 1 | Search ANTINAUSEANT | Search ANTINAUSEANT |
6 | CAS 81098 60 4 | 1 | 50% | 0% | 1 | Search CAS+81098+60+4 | Search CAS+81098+60+4 |
7 | CHOLINE ESTERASE INHIBITOR | 1 | 50% | 0% | 1 | Search CHOLINE+ESTERASE+INHIBITOR | Search CHOLINE+ESTERASE+INHIBITOR |
8 | CISPARIDE | 1 | 50% | 0% | 1 | Search CISPARIDE | Search CISPARIDE |
9 | CLAIM DATA | 1 | 50% | 0% | 1 | Search CLAIM+DATA | Search CLAIM+DATA |
10 | CYTOCHROME P 4503A4 | 1 | 50% | 0% | 1 | Search CYTOCHROME+P+4503A4 | Search CYTOCHROME+P+4503A4 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PROKINETIC AGENT | 10 | 28% | 7% | 30 |
2 | LONG QT INTERVAL | 9 | 67% | 2% | 8 |
3 | GASTROINTESTINAL MOTILITY DISORDERS | 7 | 31% | 5% | 19 |
4 | QTC PROLONGING DRUGS | 4 | 67% | 1% | 4 |
5 | INTRAVENOUS DOMPERIDONE | 3 | 30% | 2% | 7 |
6 | GASTROINTESTINAL PROKINETICS | 1 | 33% | 0% | 2 |
7 | GASTROINTESTINAL MOTOR ACTIVITY | 1 | 23% | 1% | 3 |
8 | CHRONIC DYSPEPSIA | 1 | 50% | 0% | 1 |
9 | GASTROESOPHAGEAL REFLUX PATIENTS | 1 | 50% | 0% | 1 |
10 | RESIDUE Y652 | 1 | 50% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine | 2014 | 7 | 41 | 37% |
A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data | 2012 | 8 | 13 | 31% |
Cardiac adverse effects of domperidone in adult patients: a systematic review | 2015 | 0 | 9 | 89% |
Domperidone: Review of pharmacology and clinical applications in gastroenterology | 2007 | 77 | 60 | 18% |
Application of the Bradford Hill criteria to assess the causality of cisapride-induced arrhythmia - A model for assessing causal association in pharmacovigilance | 2007 | 21 | 80 | 45% |
Review article: cardiac adverse effects of gastrointestinal prokinetics | 1999 | 91 | 58 | 31% |
CISAPRIDE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE AS A PROKINETIC AGENT IN GASTROINTESTINAL MOTILITY DISORDERS | 1988 | 198 | 59 | 41% |
Cisapride: What can we learn from the rise and fall of a prokinetic? | 2011 | 19 | 104 | 21% |
Formulary forum - Domperidone: A peripherally acting dopamine(2)-receptor antagonist | 1999 | 104 | 72 | 24% |
Coadministration of Domperidone Increases Plasma Levodopa Concentration in Patients With Parkinson Disease | 2012 | 3 | 14 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIOVASC MED MINIST EDUC | 1 | 50% | 0.2% | 1 |
2 | GASTROINTESTINAL COAGULAT DRUG PROD | 1 | 50% | 0.2% | 1 |
3 | GLORIA SHULMAN MOVEMENT DISORDERS | 1 | 50% | 0.2% | 1 |
4 | INSERMCIC 0004 | 1 | 50% | 0.2% | 1 |
5 | PHARMACOEPIDEMIOL PHARMACOTHERPAY | 1 | 50% | 0.2% | 1 |
6 | TERTIARY REFERRAL | 1 | 50% | 0.2% | 1 |
7 | GASTROENTEROL HEPATOLMED | 0 | 33% | 0.2% | 1 |
8 | LEGEL UW AGEING | 0 | 33% | 0.2% | 1 |
9 | YONGDONG SEVERANCE HOSP MED | 0 | 33% | 0.2% | 1 |
10 | DRUG RISK EVALUAT 1 | 0 | 17% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000250143 | SIBENADET HCL//BREATHLESSNESS COUGH AND SPUTUM SCALE BCSS//DAILY DIARY CARD |
2 | 0.0000232698 | 5 HT4 RECEPTORS//5 HT4 RECEPTOR//GR 113808 |
3 | 0.0000205837 | TRIMEBUTINE//TRIMEBUTINE MALEATE//CAS 39133 31 8 |
4 | 0.0000149548 | LAWN MOWER//LAWN MOWER INJURY//LAWN MOWERS |
5 | 0.0000136535 | GASTROESOPHAGEAL REFLUX//NEUROLOGICALLY IMPAIRED CHILDREN//FUNDOPLICATION |
6 | 0.0000131420 | TORSADES DE POINTES//TORSADE DE POINTES//ELECT ENGN CYBERNET |
7 | 0.0000123882 | GASTRIC ELECTRICAL STIMULATION//GASTROPARESIS//GASTRIC EMPTYING |
8 | 0.0000123370 | SUCTION CAPSULE//NORRKOPING HOSP//SUCTION BIOPSY |
9 | 0.0000114080 | SECT MOL ECOGENET//BROMOPRIDE//METOCLOPRAMIDE HYDROCHLORIDE |
10 | 0.0000114064 | FUNCTIONAL DYSPEPSIA//DYSPEPSIA//GASTRIC ACCOMMODATION |